Consumer Discretionary · Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · CIK 1180262 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $12.44Day −0.56%Mkt cap $1.3BP/E (FY) 5.7×1Y +35.7%Off 52W high −39.0%Vol (1Y) 58.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,295 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Price impliesUNDEMANDING · −4.1% growth |
| Short interest9.0% of sh out |
| Days to cover5.6d |
| 13F net flow (QoQ)−0.12% |
| Top-10 13F concentration52.8% |
| Next report (est.)2026-08-05 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)5.7× |
| Sales (TTM)$5.13B |
| Earnings (TTM)$239.8M |
| Net margin4.5% |
| ROIC36.6% |
| Total debt / EBITDA3.31× |
| YTD−3.5% |
| 1Y+35.7% |
| 3Y−23.4% |
| 5Y−75.6% |
| 10Y−63.4% |
| Since incept. (ann.)+4.8% |
Total return through 2026-07-30 · series begins 2005-07-08. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)58.8% |
| Ann. volatility (3Y)64.7% |
| Sharpe (1Y)0.76 |
| Sharpe (3Y)0.18 |
| Max drawdown (1Y)−43.2% |
| Max drawdown (3Y)−72.7% |
| Beta (3Y vs SPY)0.14 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BAUPOST GROUP LLC/MA | 9.3M | $136M | 8.96% | +0.0% |
| Route One Investment Company, L.P. | 8.2M | $121M | 7.96% | +0.8% |
| BlackRock, Inc. | 7.8M | $115M | 7.57% | +0.3% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.1M | $90M | 5.89% | new |
| RENAISSANCE TECHNOLOGIES LLC | 5.5M | $81M | 5.32% | −2.1% |
| FMR LLC | 5.3M | $78M | 5.10% | +37.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | $65M | 4.27% | new |
| GOLDMAN SACHS GROUP INC | 3.1M | $46M | 3.03% | +28.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 100.8% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 8,344,124 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-06 | $0.57 | +16.3% | $1.32B | +7.8% |
| 2025-12-31 | 2026-02-18 | — | — | $1.28B | +6.3% |
| 2025-09-30 | 2025-11-05 | $0.42 | −8.7% | $1.27B | +2.7% |
| 2025-06-30 | 2025-08-06 | $0.48 | +860.0% | $1.26B | −1.7% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-05 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Primary Reporting 49% · Others 21% · US 10% · IN 9% · MX 6%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
| EPS growth 3Y−12.0% |
| Sales growth 3Y−1.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
